Beranda › Kanker Payudara › Illinois › Cicero
Uji klinis Kanker Payudara di Cicero, IL
11 studi untuk Kanker Payudara mencari peserta di lokasi sekitar Cicero (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Menerima pesertaFase 3
- Hope And Healing Care, Hinsdale · 10 mi jauhnya
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- OSF Little Company of Mary Medical Center, Evergreen Park · 9 mi jauhnya
- Advocate Christ Medical Center, Oak Lawn · 9 mi jauhnya
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Menerima pesertaFase 3
- Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · 3 mi jauhnya
- Loyola University Medical Center, Maywood · 5 mi jauhnya
- Marjorie Weinberg Cancer Center at Loyola-Gottlieb, Melrose Park · 7 mi jauhnya
- dan 6 lainnya
E-Mindfulness Approaches for Living After Breast Cancer
Menerima pesertaFase 3
- Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · 3 mi jauhnya
- Loyola University Medical Center, Maywood · 5 mi jauhnya
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi jauhnya
- dan 1 lainnya
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Menerima pesertaFase 2
- Loyola University, Maywood · 5 mi jauhnya
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Menerima pesertaFase 3
- Loyola University Medical Center, Maywood · 5 mi jauhnya
- Advocate Christ Medical Center, Oak Lawn · 9 mi jauhnya
- Elmhurst Memorial Hospital, Elmhurst · 10 mi jauhnya
- dan 1 lainnya
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
Menerima pesertaFase 1/2
- Hope and Healing Cancer Services, Hinsdale · 10 mi jauhnya
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Menerima pesertaStudi observasional
- Advocate Christ Medical Center, Oak Lawn · 9 mi jauhnya
- Advocate Outpatient Center - Oak Lawn, Oak Lawn · 9 mi jauhnya
- Advocate High Tech Medical Park, Palos Heights · 12 mi jauhnya
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Menerima pesertaFase 3
- Loyola University Medical Center, Maywood · 5 mi jauhnya
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Menerima pesertaStudi observasional
- Affiliated Oncologists, Oak Lawn · 9 mi jauhnya
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer
Menerima peserta
- Loyola University, Maywood · 5 mi jauhnya
Uji klinis Kanker Payudara di kota lain
- New York City, NY136 studi
- Houston, TX126 studi
- Boston, MA112 studi
- Nashville, TN81 studi
- Los Angeles, CA73 studi
- Edison, NJ68 studi
- St. Louis, MO64 studi
- Queens, NY64 studi
- Durham, NC64 studi
- Chicago, IL59 studi
- Philadelphia, PA56 studi
- Dallas, TX55 studi
Studi lain di Cicero
- Kanker Paru Non-Sel Kecil24 studi
- Kanker Paru17 studi
- Kanker Prostat14 studi
- Kanker (semua jenis)13 studi
- Leukemia Mieloid Akut11 studi
- Kanker Kolorektal10 studi
- Kanker Kandung Kemih8 studi
- Melanoma7 studi
- Penyakit Kardiovaskular7 studi
- Kanker Metastatik7 studi
- Mieloma Multipel6 studi
- Limfoma Burkitt6 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.